Industry News
Quest Diagnostics Launches Molecular Cervical Cancer Test Based On National Institutes Of Health's TERC Gene Marker
Sep 01, 2012
May enhance evaluation of cancer risk in the up to 1... Read More
Cancer Gene Family Member Functions Key To Cell Adhesion And Migration
Sep 01, 2012
The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C... Read More
Cancer Gene Family Member Functions Key To Cell Adhesion And Migration
Sep 01, 2012
The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C... Read More
2 Chemo Drugs For Breast Cancer May Cause Heart Problems
Sep 01, 2012
Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health researchers and others in the Journal of the National Cancer Institute... Read More
2 Chemo Drugs For Breast Cancer May Cause Heart Problems
Sep 01, 2012
Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health researchers and others in the Journal of the National Cancer Institute... Read More
Potential New Type Of Diagnostic Imaging Technology Using Collagen-Seeking Synthetic Protein Could Lead Doctors To Tumor Locations
Aug 31, 2012
Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected... Read More
New Cancer Drug Efficiently Targets Breast, Lung And Colon Cancer; Clinical Trials Could Start Within 2 Years
Aug 31, 2012
Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs... Read More
Scientists Stop Abnormal Brain Cell Growth In Mice With Neurofibromatosis Using Experimental Tumor Drug
Aug 31, 2012
A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests... Read More
Controlling Diabetes After Pancreas Removal
Aug 31, 2012
Removing the entire pancreas in patients with cancer or precancerous cysts in part of the organ does not result in unmanageable diabetes - as many physicians previously believed, research at Mayo Clinic in Florida has found. The study, published online in the journal HPB Surgery, evaluates how well patients who had their entire pancreas removed could control their resulting diabetes... Read More
Using FDA-Approved Test, Some Lung Cancer Patients Who Could Benefit From Crizotinib Slip Through The Net
Aug 31, 2012
Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers... Read More
Previous Page Next Page